Search

Your search keyword '"Ana Ortega"' showing total 66 results

Search Constraints

Start Over You searched for: Author "Ana Ortega" Remove constraint Author: "Ana Ortega" Topic internal medicine Remove constraint Topic: internal medicine
66 results on '"Ana Ortega"'

Search Results

2. Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block

Catalog

Books, media, physical & digital resources

3. Therapeutic Potential of Extracellular Vesicles in Hypertension-Associated Kidney Disease

4. First-Line Immune Checkpoint Inhibition for Advanced Non-Small-Cell Lung Cancer: State of the Art and Future Directions

5. XPO1 Gene Therapy Attenuates Cardiac Dysfunction in Rats with Chronic Induced Myocardial Infarction

6. OA14.01 Family History of Cancer and Lung Cancer: Information from the Thoracic Tumors Registry (TTR Study)

7. Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension

8. Integrating immune checkpoint inhibitors and targeted therapies in the treatment of early stage non-small cell lung cancer: a narrative review

9. Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry

10. Decreased Urinary Levels of SIRT1 as Non-Invasive Biomarker of Early Renal Damage in Hypertension

11. First-line immune checkpoint inhibitors for extensive stage small-cell lung cancer: clinical developments and future directions

12. The Rab-Rabphilin system in injured human podocytes stressed by glucose overload and angiotensin II

13. Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis

14. Effectiveness of Pharmacokinetic/Pharmacodynamic-Guided Meropenem Treatment in Critically Ill Patients: A Comparative Cohort Study

15. 4CPS-045 Cost effectiveness analysis of meropenem dose optimisation in critical patients

16. Influence of Sex, Age, and Weight on Levetiracetam Pharmacokinetics

17. ASB1 differential methylation in ischaemic cardiomyopathy: relationship with left ventricular performance in end-stage heart failure patients

18. A radiological score for the assessment of tuberculosis progression: Validation in mouse models

19. Effectiveness of adjunctive nebulized antibiotics in critically ill patients with respiratory tract infections

21. URINARY EXOSOME MIR-146A IS A POTENTIAL MARKER OF ALBUMINURIA IN ESSENTIAL HYPERTENSION

22. TRPM7is down-regulated in both left atria and left ventricle of ischaemic cardiomyopathy patients and highly related to changes in ventricular function

23. P2.10-02 Smoking Habit in Lung Cancer in Spain

24. P2.03-16 Agreement Between Different Methodologies for Non-Invasive p.T790M and EGFR Sensitizing Mutation Testing

25. Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis

26. P2.05-12 Analysis of Biomarkers in Lung Cancer in Spain

27. P2.05-10 Liquid Biopsy: Association Between the Burden of Disease in Patients with EGFR-Mutated NSCLC and the Frequency of Its Detection in Blood

28. Thyroid hormone biosynthesis machinery is altered in the ischemic myocardium: An epigenomic study

29. Changes in human Golgi apparatus reflect new left ventricular dimensions and function in dilated cardiomyopathy patients

30. Human ischemic cardiomyopathy shows cardiac Nos1 translocation and its increased levels are related to left ventricular performance

31. Pten Positively Regulates Brown Adipose Function, Energy Expenditure, and Longevity

32. Differential gene expression of C-type natriuretic peptide and its related molecules in dilated and ischemic cardiomyopathy. A new option for the management of heart failure

33. KRAS mutations as a prognostic factor after metastasectomy in colorectal cancer patients

34. PCN150 - COST-EFFECTIVENESS ANALYSIS OF PHARMACOKINETIC-GUIDED (PK) 5-FLUOROURACIL (5-FU) DOSING WHEN COMBINED WITH LEUCOVORIN, IRINOTECAN AND OXALIPLATIN (FOLFIRINOX) CHEMOTHERAPY FOR ADVANCED PANCREAS CANCER

35. New Cell Adhesion Molecules in Human Ischemic Cardiomyopathy. PCDHGA3 Implications in Decreased Stroke Volume and Ventricular Dysfunction

36. New Altered Non-Fibrillar Collagens in Human Dilated Cardiomyopathy: Role in the Remodeling Process

37. A simple validated method for predicting the risk of hospitalization for worsening of heart failure in ambulatory patients : the Redin-SCORE

38. Patients with Dilated Cardiomyopathy and Sustained Monomorphic Ventricular Tachycardia Show Up-Regulation of KCNN3 and KCNJ2 Genes and CACNG8-Linked Left Ventricular Dysfunction

39. Radical chemoradiotherapy for patients with locally advanced esophageal cancer. Long-term follow up of an ambispective study

40. Pharmacological inhibition of PI3K reduces adiposity and metabolic syndrome in obese mice and rhesus monkeys

41. Effect of high extracellular Ca2+ levels in spontaneously hypertensive rat aorta

42. A Multinational Study to Measure the Value that Patients with Cancer Place on Improved Emesis Control Following Cisplatin Chemotherapy

43. Effects of Hepatic Function on Vancomycin Pharmacokinetics in Patients With Cancer

44. What are cancer patients willing to pay for prophylactic epoetin alfa?

45. Predictors of multivessel disease in cases of acute chest pain

46. HIGHLIGHTS ON ENDOTHELINS: A REVIEW

47. Cost–Utility Analysis of Paclitaxel in Combination with Cisplatin for Patients with Advanced Ovarian Cancer

48. MA06.07 Impact of Type 2 Diabetes Mellitus and Its Metabolic Control on Prognosis of Unresectable Non-Small Cell Lung Cancer Patients

49. Heart failure entails significant changes in human nucleocytoplasmic transport gene expression

50. Breast-GPA and type of treatment predictors of survival in brain metastasis patients